Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/25847
Title: Inhibition of steatosis and liver fibrosis progression in patients with nonalcoholic steatohepatitis and stage two essential hypertension due to the treatment with hepadif, ezetimibe and fosinopril
Authors: Mandryk, O.
Yeleniuk, I.
Stasiuk, V.
Keywords: nonalcoholic steatohepatitis
SteatoTest
FibroTest
arterial hypertension
Issue Date: 2021
Citation: Results of modern scientific research and development: Proc. of the 3rd Int. sci. and pract. conf. (May 29-31, 2021, Madrid, Spain). Madrid: Barca Academy Publishing, 2021. 675 p.
URI: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/25847
Appears in Collections:Тези

Files in This Item:
File Description SizeFormat 
Mandryk et al. Inhibition.pdf337.35 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.